Passa al contenuto

Connecting to Body Systems: How Antibody Innovation Impacts Every Major Physiological Network​


 Motor system (musculoskeletal)

Antibodies can target inflammatory markers and autoantibodies in diseases such as rheumatoid arthritis or osteoporosis, allowing for early diagnosis and personalized therapies.

Respiratory system

Monoclonal antibodies are essential in the treatment of asthma, COPD and respiratory infections because they neutralize allergens or viral pathogens such as respiratory syncytial virus or influenza.

 Endocrine system

Antibody-based tests help detect hormonal imbalances (e.g., insulin, thyroid hormones) and autoantibodies in type 1 diabetes or Graves' disease.

Nervous system

New antibodies are being used to identify neurodegenerative diseases (such as Alzheimer's through the beta-amyloid protein) and multiple sclerosis through autoimmune markers.

 

Digestive system

 Antibodies help detect H. pylori, diagnose celiac disease, and monitor inflammatory bowel disease through biomarkers such as calprotectin.

Circulatory system

 Therapeutic antibodies are used against cholesterol targets (PCSK9 inhibitors) or to detect cardiac biomarkers in the diagnosis of heart attack.

  Reproductive system

They support fertility diagnosis, detect hormonal imbalances and help identify tumors such as ovarian or prostate cancer.

Urinary system

Antibodies are used to detect markers of kidney function, urinary tract infections, or autoimmune kidney disease.

Sensory system​

Research uses antibodies to study eye diseases (macular degeneration) or autoimmune diseases of the inner ear, with emerging therapeutic roles.

Accedi per lasciare un commento